A monoarthritis case following mirtazapine use
Mirtazapine is an antidepressant drug affecting both noradrenergic and serotonergic systems with a primary use in the treatment of depression. In this report, a patient who developed monoarthritis following mirtazapine treatment with a daily dose of 30 mg, is presented. All symptoms associated with...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Mesut Çetin
2021-03-01
|
| Series: | Psychiatry and Clinical Psychopharmacology |
| Assuntos: | |
| Acceso en liña: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/388 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|